INDUCED PLURIPOTENT STEM CELL MODEL OF CHRONIC MYELOID LEUKEMIA REVEALED OLFACTOMEDIN 4 AS A NOVEL THERAPEUTIC TARGET IN LEUKEMIA STEM CELLS

被引：0
|
作者：
Suknuntha, Kran [1 ]
Ishii, Yuki [3 ]
Hu, Kejin [4 ]
Wang, Jean [3 ]
Swanson, Scott [1 ]
Stewart, Ron [2 ]
Thomson, James [2 ]
Slukvin, Igor [1 ,4 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] Morgridge Inst Res, Madison, WI USA
[3] Moores UCSD Canc Ctr, La Jolla, CA USA
[4] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA
来源：
EXPERIMENTAL HEMATOLOGY | 2013年 / 41卷 / 08期
关键词：
D O I：
10.1016/j.exphem.2013.05.066
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [31] Stem cell biomarkers in chronic myeloid leukemia
    Jiang, Xiaoyan
    Zhao, Yun
    Forrest, Donna
    Smith, Clayton
    Eaves, Allen
    Eaves, Connie
    [J]. DISEASE MARKERS, 2008, 24 (4-5) : 201 - 216
  • [32] Modeling malignancies using induced pluripotent stem cells: from chronic myeloid leukemia to hereditary cancers
    Turhan, Ali
    Foudi, Adlen
    Hwang, Jin Wook
    Desterke, Christophe
    Griscelli, Frank
    Bennaceur-Griscelli, Annelise
    [J]. EXPERIMENTAL HEMATOLOGY, 2019, 71 : 61 - 67
  • [33] Efficacy of tyrosine kinase inhibitors on a mouse chronic myeloid leukemia model and chronic myeloid leukemia stem cells
    Tanaka, Yosuke
    Fukushima, Tsuyoshi
    Mikami, Keiko
    Adachi, Keito
    Fukuyama, Tomofusa
    Goyama, Susumu
    Kitamura, Toshio
    [J]. EXPERIMENTAL HEMATOLOGY, 2020, 90 : 46 - +
  • [34] Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia
    Kinstrie, Ross
    Karamitros, Dimitris
    Goardon, Nicolas
    Morrison, Heather
    Hamblin, Mike
    Robinson, Lisa
    Clark, Richard E.
    Copland, Mhairi
    Vyas, Paresh
    [J]. BLOOD ADVANCES, 2016, 1 (03) : 160 - 169
  • [35] Lysosomes in Stem Cell Quiescence: A Potential Therapeutic Target in Acute Myeloid Leukemia
    Jain, Vaibhav
    Bose, Swaroop
    Arya, Awadhesh K.
    Arif, Tasleem
    [J]. CANCERS, 2022, 14 (07)
  • [36] Prosurvival kinase PIM2 is a therapeutic target for eradication of chronic myeloid leukemia stem cells
    Ma, Leyuan
    Pak, Magnolia L.
    Ou, Jianhong
    Yu, Jun
    St Louis, Pamela
    Shan, Yi
    Hutchinson, Lloyd
    Li, Shaoguang
    Brehm, Michael A.
    Zhu, Lihua Julie
    Green, Michael R.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (21) : 10482 - 10487
  • [37] Novel Combination Treatments Targeting Chronic Myeloid Leukemia Stem Cells
    Al Baghdadi, Tareq
    Abonour, Rafat
    Boswell, H. Scott
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (02): : 94 - 105
  • [38] Acute myeloid leukemia: therapeutic targeting of stem cells
    Pabon, Cindy M.
    Abbas, Hussein A.
    Konopleva, Marina
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26 (06) : 547 - 556
  • [39] Therapeutic targeting of acute myeloid leukemia stem cells
    Pollyea, Daniel A.
    Jordan, Craig T.
    [J]. BLOOD, 2017, 129 (12) : 1627 - 1635
  • [40] Recruiting TP53 to target chronic myeloid leukemia stem cells
    Grant, Steven
    [J]. HAEMATOLOGICA, 2020, 105 (05) : 1172 - 1174
12345